ESC

This channel contains news about the European Society of Cardiology (ESC), including coverage of its annual meeting and new guidelines. ESC is a leading resource for cardiology science and information in Europe.

Smoking traditional or non-combustible cigarettes while wearing a surgical mask results in a two-fold rise in exhaled carbon monoxide and impaired blood vessel function compared to non-mask periods

News | Cardiovascular Clinical Studies

Mask Wearing Amplifies Harms of Smoking

July 11, 2022 — Smoking traditional or non-combustible cigarettes while wearing a surgical mask results in a two-fold ...

July 12, 2022

The COVID-19 vaccination is not associated with an increased risk of heart attack or stroke in patients with established cardiovascular disease, according to a large study published in Cardiovascular Research

News | Coronavirus (COVID-19)

COVID Vaccines are Safe for Patients with Cardiovascular Disease

June 23, 2022 — The COVID-19 vaccination is not associated with an increased risk of heart attack or stroke in patients ...

June 23, 2022

Recommendations on how to use gene testing to prevent sudden cardiac death in athletes and enable safe exercise are published today in the European Journal of Preventive Cardiology

News | Heart Failure

Up to 80% of Athletes Who Die Suddenly Had No Symptoms or Family History of Heart Disease

June 22, 2022 — Recommendations on how to use gene testing to prevent sudden cardiac death in athletes and enable safe ...

June 22, 2022

Eating low glycaemic index foods promotes a healthier body shape in patients with coronary artery disease, according to a study presented at ACNAP-EuroHeartCare Congress 2022, a scientific congress of the European Society of Cardiology (ESC).

News | ESC

Low Glycaemic Index Diet Helps Heart Patients Lose Weight

June 1, 2022 — Eating low glycaemic index foods promotes a healthier body shape in patients with coronary artery disease ...

June 01, 2022

Recardio Inc., a late stage clinical-stage life science company developing regenerative therapies for cardiovascular diseases, announced that the FDA concurs with Recardio's pivotal Heal-MI Phase 3 trial design with Dutogliptin in Acute Myocardial Infarction

News | Cardiogenic Shock

Recardio and FDA Reach Agreement on Pivotal Phase 3 Trial Design

June 1, 2022 — Recardio's Phase 2 trial results demonstrated the excellent safety profile of its lead drug Dutogliptin ...

June 01, 2022

First clinical data of implantable heart sensor with remote measurement capabilities presented at prestigious Late-Breaking Science forum at the ESC Heart Failure 2022

News | Heart Failure

VECTOR-HF I Study Confirms Safety and Accuracy of V-LAP In-Heart Sensor for Left Atrial Pressure Management of Heart Failure

May 31, 2022 — Vectorious Medical Technologies Ltd., an innovator in implantable hemodynamic monitoring in heart failure ...

May 31, 2022

Research Presented at the American Heart Association’s Quality of Care and Outcomes Research (QCOR) Scientific Sessions Indicate Potential for VASCEPA (icosapent ethyl) to Reduce Major Adverse Cardiovascular (CV) Events and Associated Costs

News | Pharmaceuticals

Research Shows Potential to Reduce Major Cardiovascular (CV) Events

May 17, 2022 — Amarin Corporation plc announced that research on the potential population health impact and cost ...

May 17, 2022

Heart failure presents differently in women and men – discover the latest evidence and its impact on management at Heart Failure 2022, a scientific congress of the European Society of Cardiology (ESC).

News | ESC

Improving Outcomes for all Patients with Heart Failure

May 9, 2022 — Heart failure presents differently in women and men – discover the latest evidence and its impact on ...

May 09, 2022

News | Cardiac Rehabilitation

COVID-19 Vaccine Technique Shows Promise for Heart Disease

May 2, 2022 – A method for delivering genetic material to the body is being tested as a way to repair damaged heart ...

May 02, 2022

The annual congress of the European Heart Rhythm Association (EHRA), a branch of the ESC, will be held April 3-5 at the Bella Center in Copenhagen, Denmark and online. Explore the scientific program.

News | ESC

EHRA 2022: Cutting Edge Science in Heart Rhythm Disorders

March 31, 2022 — The annual congress of the European Heart Rhythm Association (EHRA), a branch of the ESC, will be held ...

March 31, 2022

A small study has shown that SARS-CoV-2 vaccination in patients who had an inflamed heart muscle in the past is not associated with a recurrence of the condition or other serious side effects.

News | Coronavirus (COVID-19)

Study: COVID-19 Vaccination is Safe in Patients with Previous Myocarditis

March 22, 2022 — A small study has shown that SARS-CoV-2 vaccination in patients who had an inflamed heart muscle in the ...

March 22, 2022

Women are less likely to receive lifesaving treatment for cardiogenic shock than men, according to research presented today at ESC Acute CardioVascular Care 2022, a scientific congress of the European Society of Cardiology (ESC).

News | Cardiogenic Shock

Women More Likely to Die After Heart Emergency than Men

March 22, 2022 – Women are less likely to receive lifesaving treatment for cardiogenic shock than men, according to ...

March 22, 2022

Just 76% of heart attack patients with dyspnoea or fatigue as their main symptom are alive at one year compared to 94% of those with chest pain as the predominant feature. That’s the finding of research presented today at ESC Acute CardioVascular Care 2022, a scientific congress of the European Society of Cardiology (ESC)

News | Heart Failure

Shortness of Breath Heralds Worse Survival than Chest Pain for Heart Attack Patients

March 22, 2022 – Just 76% of heart attack patients with dyspnoea or fatigue as their main symptom are alive at one year ...

March 22, 2022

European Society of Cardiology (ESC) top news stories in 2021

News | ESC